Finance & Banking

Women's Venture Capital Summit 2027

Join 400+ of the industry's most influential dealmakers, fundraisers, investors and allocators at the Women's Venture Capital Summit, a destination for senior decision-makers across the venture capital ecosystem. This retreat-style summit fosters honest conversations and genuine partnerships in a high-trust environment. Attendees connect, learn and build rel…

Visit the official site
33Speakers
0Sponsors
68On the bill · sessions
32Companies · in total
§I

Speakers

Programmed at Women's, in alphabetical order.
Ashley Neville
Director of Insights · Carta
Ava Alemazkoor
Vice President · Recast
Carolina Brochado
Head of EQT Ventures & Founding Partner · EQT Partners
Courtney McCrea
Managing Partner · Recast Capital
Diana Murakhovskaya
GP and Co-Founder · The Artemis Fund
Holly Maloney
Managing Director · General Catalyst
Jacquie Duval
Partner · Perkins Coie
Jay Graber
CEO · Bluesky
Jessica Lin
GP · Work-Bench
Julia Crosby
Managing Director · Denison University
Julia Moore
Managing Partner · Breakout Ventures
Kanu Gulati
Partner · Khosla Ventures
Kate Simpson
Managing DIrector · GEM Investments
Katherine Rodota
Associate Portfolio Manager · CalSTRS
Katie Jacobs Stanton
founder and GP · moxxie
Kelly Chen
Founder · Physical World
Khalisa Valani
Principal, Investments · OPTrust
Lila Tretikov
Partner, Head of AI Strategy · NEA
Lu Zhang
Founder & Managing Partner · Fusion Fund
Maggie Millhiser
Managing Director · Virginia Tech Foundation, Inc.
Melody Ing
Interim CIO · Berkeley Endowment Management Company
Mercedes Bent
Co-Founder & Partner · Premise
§III

Agenda

Selected from 68 sessions on the bill.
  • 10:00 AM - 10:40 AM PST / 1:00 PM - 1:40 PM Your local time (40 min)

    Crossing the Finish Line: The Strategies Needed to Raise a Fund in ‘26

    Raising a venture fund is certainly no easy task – given the shortage of exits and the pullback from some institutional investors to the asset class. But it can be done. In this im…

  • 10:15 AM - 10:35 AM PST / 1:15 PM - 1:35 PM Your local time (20 min)

    Inside TMRS’ Venture Program: Where It Sees Opportunity

    The Texas Municipal Retirement System is on a mission to increase its venture capital activity – both through expanded investing in funds and in innovative companies. During the su…

  • 10:15 AM - 10:35 AM PST / 1:15 PM - 1:35 PM Your local time(20 min)

    Inside TMRS’ Venture Program: Where It Sees Opportunity

    The Texas Municipal Retirement System is on a mission to increase its venture capital activity – both through expanded investing in funds and in innovative companies. During the su…

  • 10:35 AM - 10:55 AM PST / 1:35 PM - 1:55 PM Your local time (20 min)

    Break

  • 10:40 AM - 11:05 AM PST / 1:40 PM - 2:05 PM Your local time (25 min)

    Break

  • 10:55 AM - 11:35 AM PST / 1:55 PM - 2:35 PM Your local time (40 min)

    Track I: About Those Fund Terms….

    Fundraising can be a daunting challenge. Between identifying LPs, landing meetings and then trying to convince them to support you and your fund. Often lost in this process, though…

    Track I
  • 10:55 AM - 11:35 AM PST / 1:55 PM - 2:35 PM Your local time (40 min)

    Track III: The Push into Hardware: Will It Payoff?

    AI’s impact is also being felt in the types of companies that VCs are funding. Long focused on software and internet services, firms are deploying increasing amounts of capital int…

    Track III
  • 10:55 AM - 11:35 AM PST / 1:55 PM - 2:35 PM Your local time (40 min)

    Track II: Landing Growth Financing: What Does It Take in the Current Environment?

    Plenty of startups get funded but only a few of those will land the sizable rounds that will alter their trajectory. For VCs, these rounds can mean the difference between a good re…

    Track II
  • 10:55 AM - 11:35 AM PST / 1:55 PM - 2:35 PM Your local time (40 min)

    Track IV: Half Full or Half Empty? How Should the Biotech Sector Be Viewed?

    If you are an optimist, you would say that the biotech sector has bounced back over the past year. Financings are up. Companies are going public and pharmaceutical companies are co…

    Track IV
Intermission
Part the Second · For the Buyer

An audience of 32 companies, parsed from the program.

32 companies in attendance.

The numbers below are derived from the speakers, sponsors, and exhibitors on this page, cross-referenced into one ledger. They are the only thing here that 10times.com cannot tell you.

Who's in the room
0All threespeak · spons · exh
0Sponsoringsponsor only
32Companies Speakingspeaker only
Speakers by seniority

82% of the speakers carry senior titles: C-suite, Founder, VP, or Director-level.

  • C-suite13%
  • Founder / Owner1648%
  • VP-level13%
  • Director / Head of927%
  • Manager / Lead39%
  • Other roles39%

Of 33 on the bill · classified by free-text title

Most-represented companies
  1. 01Recast Capital2V
  2. 02Berkeley Endowment Management Company1V
  3. 03Bluesky1V
  4. 04Breakout Ventures1V
  5. 05CalSTRS1V
  6. 06Carta1V
  7. 07Denison University1V
  8. 08EQT Partners1V
  9. 09Fusion Fund1V
  10. 10GEM Investments1V
  11. 11General Catalyst1V
  12. 12IBank California1V
  13. 13IVP1V
  14. 14Khosla Ventures1V
Sponsors by tier

Tiers were not disclosed for this event.